Apogee Therapeutics Inc. share price logo

Apogee Therapeutics Inc.

NASDAQ: APGE

Large Cap

$134.59

-0.10

(-0.07%)

Live

as on

Apogee Therapeutics Inc. Stock Performance

as on August 13, 2026 at 3:09 am IST

  • Day's Low

    Day's High

    $134.56
    $134.70
    downward going graph

    0.02%

    Downside

    0.08%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $34.58
    $134.88
    downward going graph

    74.31%

    Downside

    0.22%

    Upside

    downward going graph

Apogee Therapeutics Inc. share price movements today

Previous Close
$134.69
Open
$134.70
Volume
295.7K
Day's Low - High
$134.56 - $134.70
52 Week Low - High
$34.58 - $134.88

Apogee Therapeutics Inc. Historical Returns

1 Month Return
+ 0.78 %
3 Month Return
+ 62.41 %
1 Year Return
+ 267 %
3 Year Return
+ 521.55 %
5 Year Return
0 %

Apogee Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Apogee Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$10.1B

EPS (TTM)

-4.4129

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-303.7M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-28.47%

Apogee Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Apogee Therapeutics Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$10.1BNANA0.00%NA
BUY$44.4B758.25%NA0.00%NA
BUY$132.8B171.88%28.935.00%NA
BUY$83.2B31.09%19.4227.87%0.45999999999999996%

Stock Returns calculator for Apogee Therapeutics Inc. Stock including INR - Dollar returns

The Apogee Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Apogee Therapeutics Inc. investment value today

Current value as on today

₹3,99,022

Returns

₹2,99,022

(+299.02%)

Returns from Apogee Therapeutics Inc. Stock

₹2,66,730 (+266.73%)

Dollar Impact

₹32,292 (+32.29%)

Analyst Recommendation on Apogee Therapeutics Inc. Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Apogee Therapeutics Inc.. Average target price of $130.53

Apogee Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Apogee Therapeutics Inc..

What analysts predicted

-3.11%DOWNSIDE

Target Price

$130.53

Current Price

$134.59

Analyzed by

12 Analysts

Target

$130.53

Apogee Therapeutics Inc. target price $130.53, a slight downside of -3.11% compared to current price of $134.59. According to 12 analysts rating.

Indian Investors' Interest in Apogee Therapeutics Inc. Stock

Search interest for Apogee Therapeutics Inc. Stock has decreased by -82% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-82% versus previous 30 day period

Apogee Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
0
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
Operating Income
-38
-44
-58
-75
-63
-73
-71
-78
-82
EBITDA
-32
-33
-48
-67
-55
-65
-64
-68
-73
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-32
-33
-49
-67
-55
-66
-64
-69
-74
Income Tax Expense
0
-
-
0
0
0
0
0
0
Net Income
-32
-33
-49
-67
-55
-66
-65
-69
-74
Net Profit Margin
0.00%
0.00%
0.00%
-51706.15%
0.00%
0.00%
0.00%
0.00%
0.00%

Apogee Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
Gross Profit
-
-
0
-1
Operating Income
-30
-93
-216
-285
EBITDA
-39
-74
-181
-254
Interest Expense
9
-
-
-
Depreciation
-
-
0
1
Income Before Tax
-39
-83
-182
-255
Income Tax Expense
0
0
0
0
Net Income
-39
-83
-182
-255
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Apogee Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-33
-49
-67
-55
-66
-65
-69
-74
-85
Operating Cash Flow
-29
-42
-67
-48
-62
-54
-62
-55
-71
Investing Cash Flow
-148
-146
46
12
78
17
-288
-35
-381
Financing Cash Flow
0
0
44
0
1
19
374
411
107
Change in Cash
-178
-188
23
-34
17
-16
23
320
-346

Apogee Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2023
Dec 2024
Dec 2025
Net Income
-83
-182
-255
Operating Cash Flow
-74
-171
-227
Investing Cash Flow
-273
-300
-179
Financing Cash Flow
315
495
396
Change in Cash
-33
23
-10

Global Institutional Holdings in Apogee Therapeutics Inc.

Funds
Holdings
Wellington Management Company LLP
5.79%
RTW INVESTMENTS, LLC
3.68%
HHG PLC
3.12%
State Street Corp
2.86%
T. Rowe Price Investment Management,Inc.
13.62%

Apogee Therapeutics Inc. News & Key Events

  • img

    Today's Timeline - 22 June

    Mon, 06:28 PM

    -

    AbbVie agrees to acquire Apogee for $10.9 billion, paying $135.11 per share, a 49.49% premium.

Insights on Apogee Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, APGE stock has moved up by 62.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 483.0% return, outperforming this stock by 216.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 585.4% return, outperforming this stock by 63.8%

About Apogee Therapeutics Inc.

Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis, asthma, eosinophilic esophagitis, chronic obstructive pulmonary disease, and other inflammatory and immunology indications in the United States. The company develops Zumilokibart (APG777), a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for the treatment of atopic dermatitis, which is in phase 2 clinical trials; and for the treatment of asthma and eosinophilic esophagitis which is in phase 1 clinical trial. It also develops APG279 which is in phase 1 clinical trial for the treatment of atopic dermatitis; APG273 which is in phase 1 clinical trial for the treatment of asthma and chronic obstructive pulmonary disease; and APG808, an SQ extended half-life mAb targeting IL-4Ra for the treatment of Type 2 allergic diseases. Apogee Therapeutics, Inc. was incorporated in 2022 and is headquartered in Waltham, Massachusetts.
OrganisationApogee Therapeutics Inc.
HeadquartersBuilding 17, Waltham, MA, United States, 02453
IndustryBiotechnology
CEODr. Michael Thomas Henderson M.D.
E-voting on sharesClick here to vote

Key Management of Apogee Therapeutics Inc.

Name

Title

Ms. Monica Forbes

Senior Vice President of Finance

Dr. Michael Thomas Henderson M.D.

CEO & Director

Dr. Carl Linden Dambkowski M.D.

Chief Medical Officer

Ms. Emily Cox

Senior VP & Head of People

Dr. Rebecca Dabora Ph.D.

Chief Development Officer

Dr. Drew Badger Ph.D.

Senior VP and Head of Regulatory Affairs & Toxicology

Ms. Jane Pritchett V. Henderson

Chief Financial Officer

Ms. Noel Kurdi

Vice President of Investor Relations

Mr. Matthew Batters J.D.

Chief Legal Officer & Corporate Secretary

Ms. Wendy Aspden-Curran

Senior Vice President of Clinical Operations

FAQs

What is Apogee Therapeutics Inc. share price today?

Apogee Therapeutics Inc. share price today is $134.59 as on . Apogee Therapeutics Inc. share today touched a day high of $134.70 and a low of $134.56.

What is the 52 week high and 52 week low for Apogee Therapeutics Inc. share?

Apogee Therapeutics Inc. share touched a 52 week high of $134.88 on and a 52 week low of $34.58 on . Apogee Therapeutics Inc. stock price today i.e. is trending at $134.59,which is 0.22% down from its 52 week high and 289.21% up from its 52 week low.

What is Apogee Therapeutics Inc.'s market capitalisation today?

Apogee Therapeutics Inc. market capitalisation is $0.01T as on .

How to invest in Apogee Therapeutics Inc. Stock (APGE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Apogee Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Apogee Therapeutics Inc. Shares that will get you 0.0111 shares as per Apogee Therapeutics Inc. share price of $134.59 per share as on August 12, 2026 at 9:39 pm IST.

What is the minimum amount required to buy Apogee Therapeutics Inc. Stock (APGE) from India?

Indian investors can start investing in Apogee Therapeutics Inc. (APGE) shares with as little as ₹95.32 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.20 in Apogee Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Apogee Therapeutics Inc. share’s latest price of $134.59 as on August 12, 2026 at 9:39 pm IST, you will get 0.0743 shares of Apogee Therapeutics Inc.. Learn more about fractional shares .